Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Enliven Therapeutics raised $90 million in a private placement financing to fund research and development of its clinical-stage product candidates.

PUBLIC · ELVNMar 20, 2024

Amount Raised

$90 Million

Round Type

Post-IPO Equity

BoulderBiotechnologyHealthcareHealth CareScience And EngineeringTherapeutics

Investors

Acuta Capital PartnersWoodline Partners LPLogos CapitalRock Springs CapitalVenrock Healthcare Capital PartnersFairmountCommodore Capital

Description

Enliven Therapeutics, Inc. announced a $90 million private placement financing, with participation from new and existing investors, including Commodore Capital, Fairmount, Venrock Healthcare Capital Partners, Rock Springs Capital, Logos Capital, Woodline Partners LP, and Acuta Capital Partners. The financing is expected to extend the cash runway into late 2026 and through multiple key clinical milestones for ELVN-001 and ELVN-002.

Company Information

Company

Enliven Therapeutics

Location

Boulder, Colorado, United States

About

Enliven Therapeutics is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help patients with cancer live not only longer, but better. Enliven aims to address existing and emerging unmet needs with a precision oncology approach that improves survival and enhances overall patient well-being. Enliven’s discovery process combines deep insights from clinically validated biological targets and differentiated chemistry to design potentially first-in-class or best-in-class therapies.

Fundz sees it the moment Enliven Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts17 people are listed at Enliven Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Enliven Therapeutics's next move

See what Strategic adds

Enliven Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.